Great dividend stocks should offer a mix of durability, solid income generation, and growth prospects. Read more to see 2 ...

South Korea-based Hanmi Pharmaceutical has reported positive outcomes from a Phase I/II clinical trial of Tivumecirnon ...

The company has brought the antibody to market ahead of Merck's favezelimab, which is being developed as a combination with PD-1 inhibitor Keytruda (pembrolizumab) and started a phase 3 trial in ...

He declared “We’re going to be ending global freeloading” in reference to the fact that profit margins of brand name drugs ... immuno-oncology drug Keytruda (pembrolizumab) which was ...

Studied in combination with Opdivo, Cabometyx saw RCC patients surviving 11 months longer than Sunitinib patients.

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and ...

Study shows that Libtayo plus chemotherapy has lower cost and a larger effect on improving quality-adjusted life years than Keytruda plus chemotherapy as first-line treatment for patients with ...

Let's dive into our top 10 brand design case studies. Each one of these brands nailed their visual identity in inspiring and different ways. Have you ever walked into a party and instantly known who ...

Yeah, me too. And let me tell you, it's about as fun as a root canal performed by a nervous chimp. But here's the kicker: your brand mission statement is more than just some fluffy marketing exercise.